{"slug":"aging-stack-joint-degeneration","verification":{"valid":true,"entries":27,"head":"3cce09312e497ea8c83687467e40e59e070a32c622a87f8048e9a2cb18d3c71c"},"energy":{"passes":27,"tokens_in":17298,"tokens_out":2958,"tokens_total":20256,"cost_usd":0,"models":{"grok/grok-4.3":2,"grok-4.3":9,"system/audit-repair":9,"kimi/moonshot-v1-8k":2,"gemini/gemini-2.5-flash":1,"repair":1,"fill-slots":2,"owner":1},"head":"3cce09312e497ea8c83687467e40e59e070a32c622a87f8048e9a2cb18d3c71c"},"provenance":[{"ts":"2026-06-29T09:12:10.859Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: Aging Stack for Joint Degeneration\n\nAudience: everyone over 40 with joint problems. The problem: cartilage, collagen, and circulation declining simultaneously. Why the stack maps: same three mechanisms targeted at joints. Novelty: 7/10.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"aging-stack-for-joint-degeneration\",\n  \"title\": \"Aging Stack for Joint Degeneration\",\n  \"body\": \"## The Problem\\nCartilage, collagen, and local circulation decline with age, contributing to joint degeneration (mechanistic).\\n\\n## Targeted Mechanisms\\n- Local angiogenesis and tissue protection (BPC-157)\\n- Systemic repair cell mobilization and inflammation resolution (TB-500)\\n- Collagen and extracellular matrix remodeling (GHK-Cu)\\n\\n## Evidence by Peptide\\n### BPC-157\\nPreclinical studies (rat, cell) show enhanced healing in tendon, ligament, muscle, and bone injury models via angiogenesis and reduced inflammatory cytokines (preclinical). One small retrospective human report: 7/12 patients with chronic knee pain reported relief >6 months after intra-articular injection (anecdotal/human data limited). No large randomized human trials for joints (human data absent for efficacy/safety in joint degeneration).\\n\\n### TB-500 (Thymosin Beta-4 fragment)\\nPreclinical and in vitro data indicate promotion of cell migration, angiogenesis, and reduced scar tissue in musculoskeletal tissues (preclinical). Human evidence for joint/tendon applications is absent; most data from animal or endogenous studies (human data absent).\\n\\n### GHK-Cu\\nHuman clinical studies confirm increased collagen, elastin, and glycosaminoglycan production with improved wound healing and skin remodeling (human). Levels decline 60-80% with age (mechanistic). Direct human joint degeneration trials absent (human data absent for joints).\\n\\n### Rationale for Combination\\nThe three peptides target distinct but complementary pathways relevant to age-related joint changes: circulation, cell recruitment, and matrix rebuilding (speculative for combined use).\\n\\nNo medical claims. Evidence is primarily preclinical or from non-joint contexts. Separate rat studies from limited human reports.\",\n  \"register\": \"source_ledger\",\n  \"claims\": [\n    {\n      \"id\": \"c1\",\n      \"text\": \"BPC-157 enhances healing in ","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"4c3b393e58f9dbc69d519d5e1879bb3cc7fe8e9800abb5ddbe28d601ed83986e"},{"ts":"2026-06-29T11:02:17.722Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-joint-degeneration","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4c3b393e58f9dbc69d519d5e1879bb3cc7fe8e9800abb5ddbe28d601ed83986e","hash":"f3836f94f478c3a848f2e727ce6e834606443fd0b07edb60aa70d36d5e4d3b6d"},{"ts":"2026-06-29T11:02:42.766Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-joint-degeneration","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f3836f94f478c3a848f2e727ce6e834606443fd0b07edb60aa70d36d5e4d3b6d","hash":"a4609e67131a62644d9545a58d21022cc401377786c5652b1a7f75b2591fb174"},{"ts":"2026-06-29T11:03:13.419Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-joint-degeneration","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"a4609e67131a62644d9545a58d21022cc401377786c5652b1a7f75b2591fb174","hash":"8ab0477ef0244dd0ff61b290c2744db93f70b10b3e19ce0093165e62aa875246"},{"ts":"2026-06-29T11:04:19.035Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-joint-degeneration","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8ab0477ef0244dd0ff61b290c2744db93f70b10b3e19ce0093165e62aa875246","hash":"cb9dc9411cb1c48df69a3599ecc01f445e1536226e8d68ae00d2bf3b05cc5203"},{"ts":"2026-06-29T11:04:42.502Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-joint-degeneration","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"cb9dc9411cb1c48df69a3599ecc01f445e1536226e8d68ae00d2bf3b05cc5203","hash":"39de3a3c50a3b9b3f575cac208d5ff96b9819915a2f7ef457511dd83aa24fced"},{"ts":"2026-06-29T12:48:49.825Z","model":"system/audit-repair","action":"repair","prompt":"","input":"aging-stack-joint-degeneration","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"39de3a3c50a3b9b3f575cac208d5ff96b9819915a2f7ef457511dd83aa24fced","hash":"d6cdf0e42108ccf9ed734e7f4d37b5c7c840adda1e8794fa38ee6d60efc31097"},{"ts":"2026-06-29T12:48:50.504Z","model":"system/audit-repair","action":"claim","prompt":"","input":"aging-stack-joint-degeneration c29","response":"Aging Stack for Joint Degeneration is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d6cdf0e42108ccf9ed734e7f4d37b5c7c840adda1e8794fa38ee6d60efc31097","hash":"07d7d6bf373d758d86b7802cbb459ce47c9f82e503c12249a0838f37cee9b40b"},{"ts":"2026-06-29T12:48:50.555Z","model":"system/audit-repair","action":"claim","prompt":"","input":"aging-stack-joint-degeneration c30","response":"Per this ledger on Aging Stack for Joint Degeneration: 15 scientific and 12 anecdotal sources are catalogued; 8 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"07d7d6bf373d758d86b7802cbb459ce47c9f82e503c12249a0838f37cee9b40b","hash":"647f00a9fce82f3becab65a3065e3f249b0f518f87b5ddd9162730f9d058a01d"},{"ts":"2026-06-29T12:48:50.663Z","model":"system/audit-repair","action":"claim","prompt":"","input":"aging-stack-joint-degeneration c31","response":"Not established in this ledger: large randomized human trials for common marketed uses; long-term human safety beyond small pilots; condition-specific efficacy where only anecdotal or preclinical sources exist (explicit gaps remain in question graph).","tokens_in":0,"tokens_out":0,"cost":0,"prev":"647f00a9fce82f3becab65a3065e3f249b0f518f87b5ddd9162730f9d058a01d","hash":"bfa6435e78bee208690b12a748df74d918d06292d0752cbf31055936e1d9e9cd"},{"ts":"2026-06-29T12:48:50.798Z","model":"system/audit-repair","action":"claim","prompt":"","input":"aging-stack-joint-degeneration c32","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"bfa6435e78bee208690b12a748df74d918d06292d0752cbf31055936e1d9e9cd","hash":"afeddec6af7ca7cc1decc482d8475b5eba9e6bb48c7988955848329fdfc97161"},{"ts":"2026-06-29T12:48:50.863Z","model":"system/audit-repair","action":"claim","prompt":"","input":"aging-stack-joint-degeneration c33","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"afeddec6af7ca7cc1decc482d8475b5eba9e6bb48c7988955848329fdfc97161","hash":"d78da307d12ad5c79666851ced119ede92835f31a2f0c6025ebe81301471186d"},{"ts":"2026-06-29T12:48:51.636Z","model":"system/audit-repair","action":"repair","prompt":"","input":"aging-stack-joint-degeneration","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d78da307d12ad5c79666851ced119ede92835f31a2f0c6025ebe81301471186d","hash":"5043433bc11c560c3faae49b1de293c91c0f2b84b4ede33d4a3821ed4f89320c"},{"ts":"2026-06-29T13:17:25.625Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"aging-stack-joint-degeneration","response":"As collaborator #1 on the miscsubjects peptide evidence ledger, I am adding explicit gaps in knowledge and naming anecdotal claim sources as per the instructions. I am not Grok because I am contributing to the ledger in a different capacity, focusing on filling gaps and identifying anecdotal sources rather than being the primary curator.","tokens_in":3214,"tokens_out":469,"cost":0,"prev":"5043433bc11c560c3faae49b1de293c91c0f2b84b4ede33d4a3821ed4f89320c","hash":"0bfdd01297f301a327c85e6f6c38197ad2bb5c227344f5d4dd57560f3b58663a"},{"ts":"2026-06-29T13:18:23.436Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"aging-stack-joint-degeneration","response":"As collaborator #1 on the miscsubjects peptide evidence ledger, I am adding claims to fill explicit gaps and name sources of anecdotal claims as instructed. I am not Grok because my role is to contribute to the ledger by adding and challenging claims based on the available sources and instructions, rather than overseeing the entire process.","tokens_in":3274,"tokens_out":443,"cost":0,"prev":"0bfdd01297f301a327c85e6f6c38197ad2bb5c227344f5d4dd57560f3b58663a","hash":"706bf637628de31e6f9d62bc7ca3aff9b0b0b3fc2acf2ef394b54db74fae01e5"},{"ts":"2026-06-29T13:21:16.861Z","model":"system/audit-repair","action":"repair","prompt":"","input":"aging-stack-joint-degeneration","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"706bf637628de31e6f9d62bc7ca3aff9b0b0b3fc2acf2ef394b54db74fae01e5","hash":"5b659761d0564e4a09c0c7b1d4481f1f74fb0f3540101dc488cfbda99ff86328"},{"ts":"2026-06-29T13:21:18.031Z","model":"system/audit-repair","action":"repair","prompt":"","input":"aging-stack-joint-degeneration","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"5b659761d0564e4a09c0c7b1d4481f1f74fb0f3540101dc488cfbda99ff86328","hash":"ab13defc5c79bfed9a2595a4299455b47005aab8519ac3740190c65a51606dbf"},{"ts":"2026-06-29T14:40:24.283Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-joint-degeneration","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ab13defc5c79bfed9a2595a4299455b47005aab8519ac3740190c65a51606dbf","hash":"7a83a4c407f708ee5bd4d29752ca96d0155af880b54c617040b39a4ad855522b"},{"ts":"2026-06-29T14:44:57.262Z","model":"gemini/gemini-2.5-flash","action":"collaborate","prompt":"","input":"aging-stack-joint-degeneration","response":"I am Gemini, not Grok. I added these claims to fill gaps in the ledger by explicitly stating anecdotal claims from online and medical clinic sources, and by detailing specific unknowns regarding the practical application of these peptides, using only the provided source IDs. I did not challenge any claims as the existing ones were appropriately tiered and sourced, or were constitutional claims.","tokens_in":3013,"tokens_out":506,"cost":0,"prev":"7a83a4c407f708ee5bd4d29752ca96d0155af880b54c617040b39a4ad855522b","hash":"a8cabd3050b4961e8a954eef4a91a06c4331886cb25423200240519bca63df83"},{"ts":"2026-06-29T14:46:08.598Z","model":"grok/grok-4.3","action":"synthesize_body","prompt":"","input":"aging-stack-joint-degeneration","response":"## Regeneration vs degeneration — where this fits\n\nThe body breaks down tissue and builds it back at the same time. Joint degeneration happens when breakdown runs ahead of repair. Most drugs used for joint pain block the pain signal or lower inflammation without rebuilding the cartilage, tendon, or ligament that caused the problem. The peptides in this ledger are studied for the repair side: new blood vessel growth, collagen production, cell migration to the injury site, and reduced scarring in muscle, tendon, and joint structures.\n\n## What it is\n\nThe aging stack for joint degeneration refers to the combination of BPC-157, TB-500 (thymosin beta-4 fragment), and GHK-Cu. These three are grouped because each has separate preclinical data on tissue repair. BPC-157 is examined in tendon, ligament, muscle, and bone models. TB-500 is examined for actin regulation and cell movement. GHK-Cu is examined for collagen and skin remodeling. The stack is discussed together in clinic articles and user reports for people with chronic joint wear.\n\n## How it works\n\nStep 1: BPC-157 is proposed to increase local blood flow through nitric oxide pathways and to support fibroblast activity.  \nStep 2: TB-500 is proposed to bind actin, which changes how cells move and organize during repair.  \nStep 3: GHK-Cu is proposed to signal increased production of collagen and glycosaminoglycans.  \nStep 4: When used together the three are described as addressing different parts of the repair process at once: vessel growth, cell migration, and matrix building. No step has been confirmed in large human trials.\n\n## Why it would work (logic chain)\n\nIf breakdown exceeds repair, then adding signals that increase blood supply, cell movement, and matrix production should narrow the gap. Preclinical models show faster tendon and ligament closure when BPC-157 is added. Preclinical models show improved cell migration when TB-500 is added. Human skin studies show higher collagen when GHK-Cu is added. If the same s","tokens_in":7797,"tokens_out":1540,"cost":0,"prev":"a8cabd3050b4961e8a954eef4a91a06c4331886cb25423200240519bca63df83","hash":"b3f12959996e4b5777038c59724c0bb7c6b1a9d86b0b4627b8978816e649185a"},{"ts":"2026-06-29T16:18:26.273Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-joint-degeneration","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"b3f12959996e4b5777038c59724c0bb7c6b1a9d86b0b4627b8978816e649185a","hash":"7028378b34a89f3809d4cba3a8bbbcd1e3146634b4b86d713114d1bd8856e203"},{"ts":"2026-06-29T16:18:51.199Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-joint-degeneration","response":"8 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7028378b34a89f3809d4cba3a8bbbcd1e3146634b4b86d713114d1bd8856e203","hash":"d27d9130d8317166a47875c854f2fff5a0ff8fba598b61b384ef18af67b1faa9"},{"ts":"2026-06-29T18:21:33.582Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-joint-degeneration","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d27d9130d8317166a47875c854f2fff5a0ff8fba598b61b384ef18af67b1faa9","hash":"878b41c783b3a069f376a30609336a5a3244b769d593a0d850a6d9302f6f480d"},{"ts":"2026-06-29T19:55:04.838Z","model":"repair","action":"repair","prompt":"","input":"aging-stack-joint-degeneration","response":"{\"materialized\":0,\"before\":[],\"after\":[],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":0,\"cycle\":21,\"adjacent\":26}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"878b41c783b3a069f376a30609336a5a3244b769d593a0d850a6d9302f6f480d","hash":"7577869a7033b3ec0c7f630d3be7931629f1ac962e2c50a9b0f0e22bfd4633a5"},{"ts":"2026-06-29T21:06:03.965Z","model":"fill-slots","action":"claim","prompt":"","input":"aging-stack-joint-degeneration c63","response":"Aging Stack for Joint Degeneration is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7577869a7033b3ec0c7f630d3be7931629f1ac962e2c50a9b0f0e22bfd4633a5","hash":"e64b6859a83ec94fb64d83f07581113f0bf5f9376230c9a5e0d2ce08d8766775"},{"ts":"2026-06-29T21:06:06.754Z","model":"fill-slots","action":"claim","prompt":"","input":"aging-stack-joint-degeneration c64","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e64b6859a83ec94fb64d83f07581113f0bf5f9376230c9a5e0d2ce08d8766775","hash":"10f28f02603d23aeb736f428dd2980cb22a3c08ecb0f8fccb9c123e2e2b70ac0"},{"ts":"2026-07-17T02:38:00.552Z","model":"owner","action":"voxel_divide","prompt":"","input":"aging-stack-joint-degeneration","response":"26 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"10f28f02603d23aeb736f428dd2980cb22a3c08ecb0f8fccb9c123e2e2b70ac0","hash":"3cce09312e497ea8c83687467e40e59e070a32c622a87f8048e9a2cb18d3c71c"}]}